Pre-docking filter for protein and ligand 3D structures by Wilantho, Alisa et al.
Bioinformation by Biomedical Informatics Publishing Group                             open access 
 www.bioinformation.net                                                             Hypothesis 
____________________________________________________________________________________________________    
 
ISSN 0973-2063 (online) 0973-8894 (print)                                                                        
Bioinformation 3(5): 189-193 (2008) 
Bioinformation, an open access forum 
© 2008 Biomedical Informatics Publishing Group 
189
 
Pre-docking filter for protein and ligand 3D 
structures 
 
 
Alisa Wilantho
1, Sissades Tongsima
1 and Ekachai Jenwitheesuk
1, * 
 
1National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, 113 Thailand 
Science Park, Phahonyothin Road, Klong 1, Klongluang, Pathumtani 12120, Thailand;   
Ekachai Jenwitheesuk* - Email : ekachai@biotec.or.th; Phone: 66 2564 6700; Fax: 66 2564 6701; * Corresponding author 
 
received November 15, 2008; accepted December 01, 2008; published December 31, 2008 
 
Abstract: 
Virtual drug screening using protein-ligand docking techniques is a time-consuming process, which requires high 
computational power for binding affinity calculation. There are millions of chemical compounds available for docking. 
Eliminating compounds that are unlikely to exhibit high binding affinity from the screening set should speed-up the virtual 
drug screening procedure. We performed docking of 6353 ligands against twenty-one protein X-ray crystal structures. The 
docked ligands were ranked according to their calculated binding affinities, from which the top five hundred and the bottom 
five hundred were selected. We found that the volume and number of rotatable bonds of the top five hundred docked ligands 
are similar to those found in the crystal structures and corresponded with the volume of the binding sites. In contrast, the 
bottom five hundred set contains ligands that are either too large to enter the binding site, or too small to bind with high 
specificity and affinity to the binding site. A pre-docking filter that takes into account shapes and volumes of the binding 
sites as well as ligand volumes and flexibilities can filter out low binding affinity ligands from the screening sets. Thus, the 
virtual drug screening procedure speed is increased. 
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Background: 
Virtual screening techniques are becoming increasingly 
more important in drug discovery. A popular method for 
virtual screening is molecular docking [1, 2], which selects 
small-molecule structures from databases such as 
ChemBank  [3], ChemPDB [4], KEGG [5], and NCI [6] 
and docks them into the protein binding site [7]. These 
processes involve the prediction of binding energies and 
analysis of molecular binding modes, which are time 
consuming and computationally expensive. The two-
dimensional (2D) fingerprint technique, a virtual screening 
method which measures the structural similarity of 
molecules has been developed to address the above 
problems  [8]. The similarity search is based upon the 
“similar property principle”, which states that molecules 
that are structurally similar are likely to have similar 
properties  [9]. This technique uses a ligand with known 
chemical properties, inhibitory activities, or binding modes 
for a target of interest as a reference for searching similar 
ligands in the database regardless of the shape and size of 
the protein binding site. The accuracy of this method 
depends on which similarity coefficient is used [10-12], 
and the Tanimoto coefficient is most popularly employed 
[13]. Based on the “lock-and-key” principle, we propose a 
novel pre-docking procedure that matches the sizes of the 
ligand with the protein binding site, and optimizes the grid-
box size before docking. This simple procedure 
dramatically reduces the size of screening ligand sets, 
significantly reducing time and effort required for virtual 
drug screening. 
 
 
 
Methodology: 
 
Preparation of ligand and protein structures for 
docking 
 
Preparation of ligand structures
The ligands used in this study were downloaded from 
Ligand.Info Meta-Database [14]. Ligands set-1 consisted 
of 2344 structures from ChemBank and set-2 consisted of 
4009 structures from ChemPDB. The downloaded ligands 
in the SDF format were first converted to the Protein Data 
Bank (PDB) format using Open Babel [15]. The Gasteiger 
charges and rotatable bonds were then assigned to the PDB 
ligands using AutoDockTool [16]. All rotatable bonds 
were allowed to move freely. 
 
Preparation of protein structures
Twenty-one protein X-ray crystal structures from the 
Protein Data Bank [17] were downloaded. The proteins 
and their PDB structure identifiers (PDB ID) are given in 
Table 1 (supplementary material). Of the twenty-one 
protein structures, sixteen have co-crystallized ligands (X-
ray ligand) in the binding site. The ligand contained in 
each protein structure was removed from the binding site 
and saved to a new file. The missing atoms in each protein 
structure were searched for and fixed using SwissPDB 
[18]. The Gasteiger charges and the solvation term were 
then added to the protein structure using the 
AutoDockTool. 
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Ligand SMILES string similarity search
The ligands extracted from the X-ray crystal structure 
obtained from the previous step were converted to the 
SMILES string format, and used as an input for similarity 
search against the ligands in the ChemBank and the 
ChemPDB sets in step of the Preparation of ligand 
structures using Tanimoto coefficient cutoffs of 0.5, 0.6, 
and 0.7, respectively. 
 
Calculation of ligand molecular volume 
The volumes of the ligands in the screening set were 
calculated using Mol_Volume version 1.0 [19]. The van 
der Waals radii value for each atom type was derived from 
the CHARMM 22 force field. The radius of the spherical 
probe (R_PROBE) was set to 2.0 Å, and the GRID_STEP 
was set to 0.5 Å. The volumes of the ligands extracted 
from the X-ray crystal structures were calculated using the 
same protocol. The extracted ligand name (X-ray ligand) 
and its calculated volumes are shown in Table 2 
(supplementary material). 
 
Calculation of protein binding site molecular volume 
Protein binding site volumes were calculated using the 
CASTp server (http://sts-fw.bioengr.uic.edu/castp) [20]. 
The solvent probe radius used for volume calculation was 
1.4 Å. CASTp identifies all surface pockets with the 
chosen volume values, and then displays them on the 
computer screen. Pockets calculated by CASTp that 
matched the pocket resolved by crystallography were 
selected, and the volume of that calculated pocket was 
taken as the volume of the protein binding site.  
 
Protein-ligand docking  
Grid-box generation 
The grid parameter file of each protein was generated 
using AutoDockTool. A grid-box was generated that was 
large enough to cover the entire protein binding site and 
accommodate all ligands to move freely. The number of 
grid points in x, y, and z-axes were 60×60×60. The 
distance between two connecting grid points was 0.375 Å. 
The center of the ligand in the X-ray crystal structure was 
used as the center of the grid-box. For protein structures 
that do not have ligands in the binding site, the center of 
the binding site was estimated from the structure and taken 
as the center of the grid-box. 
 
Ligand docking 
AutoDock4 and a Lamarckian Genetic Algorithm (LGA) 
[21] were used for protein-fixed ligand-flexible docking 
calculations. Ten search attempts (ga_run parameter) were 
performed for each ligand. The maximum number of 
energy evaluations before the termination of LGA run was 
2500000 and the maximum number of generations of the 
LGA run before termination was 27000. Other docking 
parameters were set to the software’s default values. After 
docking, the ligands were ranked according to their 
protein-ligand affinity (calculated inhibitory constant, Ki).  
 
Discussion: 
Size and shape of protein binding site 
  In this study, we categorized protein binding sites 
according to their sizes and shapes. Protein binding sites 
were classified as small (less than 1200 Å
3) or large 
(greater than or equals to 1200 Å
3). Protein binding site 
shapes were classified as either simple or complex. The 
protein binding site classifications are shown in Table 1 
(supplementary material). Sixteen protein structures had 
co-crystallized ligands bound in the binding site. The 
calculated volumes show that the majority of ligands are 
larger (305–5922 Å
3) than the binding sites (1040–2690 
Å
3) in particular those in the small binding site group. 
However, the average volumes of the ligands (1684 Å
3) 
and the binding sites (1638 Å
3) are very similar. The 
protein binding site typically accommodates 50–70% of 
the ligand, with the remainder of the ligand occupying 
pockets adjacent to the binding site. For example, 50% of 
the GDP ligand (volume = 1460 Å
3) was contained within 
the small binding pocket (volume = 594 Å
3) of the 
“Filamenting temperature-sensitive mutant Z” protein 
(PDB ID: 1RQ7), while the rest of GDP ligand occupied 
pockets close to or floating over the binding site. This 
suggests that the optimal ligand size can potentially exceed 
the binding site volume. 
 
X-ray ligand docking and ranking 
To verify the docking procedure utilized in this work, we 
re-docked the original X-ray ligand back to its 
corresponding protein binding site. The X-ray ligands 
along with all other ligands in the screening set were 
ranked according to the calculated Ki. The X-ray ligands 
were ranked in the top ten percentiles and were also able to 
move back to the original positions with the root mean 
square deviations of less than 3 Å. 
 
Docked ligand size and flexibility 
The top 500 and the bottom 500 ligands ranked according 
to the Ki value for each protein were selected for further 
analysis. A scatter plot of the molecular volumes and the 
number of active torsion bonds for these ligands is shown 
in  Figure 1. The top 500 ligands are clearly coincident 
with the sixteen X-ray ligands, which occupy volumes of 
800-2800 Å
3, whereas the bottom 500 ligands occupy 
volumes outside this range, with 95% much smaller (300–
900 Å
3). There does not appear to be any correlation 
between the number of active torsion bonds and calculated 
Ki; however, the majority of the top 500 ligands have 
twenty or fewer active torsion bonds. These data suggest 
that ligands with high binding affinity are constrained by 
their size (volume 800–2800 Å
3) and flexibility (20 or 
fewer active torsion bonds). For untested ligands, these 
parameters could be useful to prioritize docking 
calculations, so that priority is given to ligands of optimal 
size and flexibility. 
 
Optimal size of the grid-box 
In this study, a very large grid-box (10830 Å
3, 22.125 Å on 
each side) was used because we wanted to ensure that the 
grid-box could cover the entire binding site, and that all 
ligands in the screening sets had enough space to enter and 
move freely in the grid-box. The volume of the grid-box 
was 10830 Å
3 while the volume of the largest protein 
binding site was only 5921.8 Å
3 (PDB ID: 1N8W). We 
hypothesized that using a very large grid-box would allow 
the binding of some ligands to extend beyond the actual 
binding site, with non-specific binding into adjacent 
pockets. We tested this hypothesis by generating minimal Bioinformation by Biomedical Informatics Publishing Group                             open access 
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grid-boxes that perfectly encompassed the entire binding 
site for each protein. The box sizes and their dimensions 
are shown in Table 3 (supplementary material). The top 
500 ligands were left on protein at the docked positions.
 
Figure 1: The volume and the number of active torsion bonds of the top 500 (red) and the bottom 500 docked ligands (blue) 
ranked according to the calculated inhibitory constant (Ki). Of the twenty-one protein X-ray crystal structures used in this 
study, sixteen structures had ligand bound in the binding site. The top 500 ligands generally had structural profiles in terms 
of volume and number of active torsion bond similar to those of the X-ray ligands (green) while the bottom 500 ligands 
were, on average, 800-900 Å
3 smaller than the X-ray ligands. 
 
Filtering of the top 500 docked ligands was performed to 
test how ligands occupy space beyond the protein binding 
site. Six thresholds of decreasing stringency, allowing 
progressively more of the ligand atoms to be outside the 
minimal grid–box were used (Table 4  in  supplementary 
material). It is clear that on average, the top 500 ligands 
cannot fit entirely within the minimal grid-boxes extending 
outside them, since 10.8% of the ligands were rejected, 
even when a very relaxed 30% threshold was employed 
(Table 4 in supplementary material). Visual inspection of 
the docked structures revealed that the protein binding sites 
contain at least one opening space, and parts of the docked 
ligands were always outside of the minimal box on this 
side. The rejected ligands might be either too large or too 
long to fit entirely within the minimal box, or their 
chemical properties may not match perfectly well with the 
binding pocket so that parts of their structures bind 
preferentially with adjacent pockets. 
 
Reducing the grid-box size would significantly reduce 
CPU time for docking calculation, an important 
consideration for drug-discovery when potentially millions 
of compounds are screened. However, it is clear from our 
data that this would also increase the false negative rate, 
leading to some high binding-affinity ligands to be missed. 
These false-negatives would likely include molecules with 
long linear shapes, or with branches which extend beyond 
the target binding site and bind to adjacent pockets, in 
particular on the opening space side (see above). We 
propose that the optimal grid-box size allows 
approximately two-thirds of ligand molecule to occupy the 
target binding site, with the remaining one third able to 
bind with adjacent pockets. Grid-boxes of this size provide 
the optimal balance between the number of screening 
ligands and the CPU time required for docking. 
 
SMILES strings similarity of the docked ligands and 
the X-ray ligands 
We further explored whether the top 500 and the bottom 
500 ligands docked on each protein were chemically 
similar to the X-ray ligand extracted from the protein-
ligand co-crystal structures using the SMILES strings 
similarity search. The results show that, in general, more of 
the top 500 ligands matched with the X-ray ligands than of 
the bottom 500 ligands (Table 5 in supplementary 
material). On the other hand, even at a Tanimoto 
coefficient of 0.5, only thirteen ligands in the top500 list 
matched with the X-ray ligand. This indicates that most of 
the potential hits were chemically dissimilar to the X-ray 
ligands, yet similar in size as discussed above. Conversely, 
at a Tanimoto coefficient of 0.5, six out of the bottom 500 
ligands matched with the X-ray ligand, suggesting that 
these ligands although similar to the X-ray ligand have 
chemical properties that are unfavorable to interactions 
with the binding site. 
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Conclusion: 
There are millions of ligand structures currently available 
in public databases. Virtual screening of these ligands 
against a protein target using protein-ligand docking 
methods requires lengthy calculations on a high 
performance computer. This is a major obstacle that 
prevents several research groups in academia, especially 
those with limited computer resources to conduct research 
in this field. To overcome this problem, several 
computational techniques have been developed to reduce 
the calculation time. In this study, we show that ligand size 
may be used as an initial criterion for prioritizing ligands 
for docking. The ligands that are greatly different in size to 
that of the X-ray ligand, or to the binding site volume may 
be set to have low priority for screening or removed from 
the screening set, since  these usually have low calculated 
binding affinity (Ki). On the other hand, ligands of 
optimum size within ±1000 Å
3 of the X-ray ligand or 
binding site volume may be assigned higher priority since 
they tend to bind with higher calculated affinity. In 
addition to clustering ligands into groups, adjusting the 
grid-box size would also help limit the number of ligands 
to be screened. The optimum grid-box allows one-third of 
the ligand to lie outside of the target binding site. Our new 
screening procedure, which takes into account the ligand 
size, the binding site volume, and the grid-box size, is easy 
to perform and could significantly reduce time and effort 
required for virtual drug screening.  
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Supplementary material 
 
PDB ID 
Binding site volume 
Binding site shape 
Small Large 
 1OKE  NA 
 1CET  NA 
1ZNY 1M4D 
1C3V 1LQU 
 
2FOM 1P44 
1ZAU 1EYE 
1K44 1F61 
Simple 
 
   2DEN 
Irregular shape  1R6A  1ENY 
and varied depth  1RQ7    
L-shape with  1DF7  1MRN 
1N2B 
2C27 
Complex 
varied depth 
  
  
  
  
1N8W 
Table 1: Shape and size of the protein binding sites is shown. The binding sites were divided into groups according to their 
shapes (simple and complex) and sizes (small; volume <1200 Å
3 and large; volume ≥1200 Å
3). 
 
Protein Ligand    
PDB ID  Name Binding  site 
volume(Å
3) 
Name volume 
(Å
3) 
No. of 
active torsion 
1C3V Dihydrodipicolinate  reductase  668  NA  NA  NA 
2FOM NS2B-NS3  protease  828  NA  NA  NA 
1K44  Nucleoside diphosphate kinase  1012  NA  NA  NA 
1F61 Isocitrate  lyase  2735 NA  NA  NA 
2DEN Helicase  5071  NA  NA  NA 
1R6A Methyltransferase  305 RVP  1210  4 
1RQ7  Filamenting temperature-sensitive mutant Z  594  GDP  1460  6 
1ZNY Guanylate  kinase  664 GDP  1460  6 
1DF7 Dihydrofolate  reductase  752  MTX  1790  8 
1ZAU  NAD+ dependent DNA ligase  904  AMP  1240  4 
1OKE  Envelope glycoprotein E  1044  BOG  1310  6 
1CET Lactate  dehydrogenase  1074 CLQ  1410  8 
1MRN Thymidylate  kinase  1268  T5A  2690  16 
1M4D Aminoglycoside  2’-N-acetyltransferase 1422  TOY  1680  6 Bioinformation by Biomedical Informatics Publishing Group                             open access 
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1LQU Mycobacterial  oxidoreductase  1474 NDP  2400  13 
1ENY  Enoyl-acyl carrier protein reductase  1657  NAD  2180  11 
1P44 Enoyl  reductase  1692  GEQ  1600  2 
1N2B Pantothenate  synthetase  2008 APC  1570  8 
1EYE 6-Hydroxymethyl-7,8-dihydropteroate 
synthase 
2278 PMM  1040  3 
2C27 Mycothiol  synthase  3150  MA8  1540  6 
1N8W Malate  synthase  5922 COA  2370  18 
Table 2: Details of protein and ligand X-ray crystal structures used in this study. 
 
PDB ID  Box center   coordinate on  
x, y, z axes 
No. of axis points 
on x, y, z axes 
1C3V  134.796  25.327  22.087  40×50×40 
2FOM   -4.451 -10.488  17.047  50×40×50 
1K44   26.365  42.416  51.116  40×40×40 
1F61   37.471  66.151   4.837  40×44×40 
2DEN   -0.719   1.110  52.523  40×50×60 
1R6A   16.498 -52.304  16.284  40×40×46 
1RQ7   -8.274  37.324   7.065  40×40×40 
1ZNY   24.782   8.849  30.726  40×40×40 
1DF7    1.827  27.794  10.958  40×40×40 
1ZAU  -10.553  43.872  68.997  40×40×40 
1OKE  -11.491  80.375  45.517  60×40×40 
1CET   35.592  12.727  18.358  40×40×40 
1MRN   25.094  14.419   2.243  40×50×46 
1M4D   20.818  29.061  13.435  40×40×40 
1LQU   -4.075  -3.490   5.319  50×40×40 
1ENY   -1.139  33.283  13.766  45×45×40 
1P44   15.210  14.125   8.359  40×46×40 
1N2B   34.878  35.004  40.786  40×40×40 
1EYE   32.818   4.458  38.753  40×40×40 
2C27    4.671   3.124  18.325  40×40×40 
1N8W   15.581  32.585  77.100  40×50×40 
Table 3: The coordinates of the grid-box center and the number of grid points on the x, y, and z axes in grid-boxes of 
minimum size is given. The distance between grid points was 0.375 Å. 
 
Percentage of ligand atoms allowed outside of the box  PDB ID 
5% 10% 15% 20% 25% 30% 
1C3V  64.2 59.8 54.6 51.2 49.2 46.4 
2FOM  59.2 40.0 23.4 13.2    8.6    5.6 
1K44  73.4 60.6 45.8 30.6 18.8 11.4 
1F61  88.4 76.6 65.2 50.4 38.2 27.2 
2DEN   6.4   3.0   1.2   0.4   0.4   0.4 
1R6A  50.8 36.8 24.2 16.2 11.8    8.4 
1RQ7  52.0 39.0 25.6 16.8    9.0    5.8 
1ZNY  78.4 63.2 51.8 39.2 27.6 18.6 
1DF7  37.8  23.4  13.8   8.4   5.4   3.0 
1ZAU  52.0 47.0 39.6 31.4 21.8 14.4 Bioinformation by Biomedical Informatics Publishing Group                             open access 
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1OKE  12.8   7.6   3.6   1.8   1.0   0.8 
1CET  61.4 47.6 34.8 23.2 15.0    8.4 
1MRN  42.6  24.2  14.2   5.4   1.8   0.8 
1M4D  38.0 29.0 19.8 13.6    9.2    5.2 
1LQU  34.6  17.8  10.4   5.6   3.0   1.8 
1ENY  40.2 22.6 11.8  5.6    2.2    1.2 
1P44  41.4 31.6 22.4 14.0    9.6    6.0 
1N2B  64.0 53.8 44.8 33.8 24.2 15.8 
1EYE  95.6 89.2 78.8 64.2 49.4 39.6 
2C27  42.8 29.0 20.4 14.0    6.2    3.6 
1N8W  49.4  27.2  16.2   9.6   4.8   2.8 
Average 51.6 39.4 29.6 21.3 15.1 10.8 
Table 4: Percent of ligands rejected from the top500 ligand list docked with twenty-one protein binding sites and minimal 
grid-boxes (see Table 3). Six thresholds for rejection were tested, in which the percentage of ligand atoms outside of the 
grid-box was varied. 
 
TC = 0.7  TC = 0.6  TC = 0.5  PDB ID  Ligand 
name  Top 
500 
Bottom 
500 
Top 
500 
Bottom 
500 
Top 
500 
Bottom 
500 
1R6A  RVP  1  0 19  0 47  0 
1ZNY  GDP  0  0 1  1 2  14 
1DF7  MTX  7  0 15  0 24  0 
1ZAU  AMP  2  0 3  0 7  6 
1OKE  BOG  0  0 0  0 0  0 
1CET  CLQ  0  0 0  0 0  0 
1MRN T5A  1  0 11  2 23  16 
1M4D  TOY  0  0 0  0 1  0 
1LQU NDP  8  0 13  4 21  4 
1ENY  NAD  1  0 4  0 5  3 
1P44  GEQ  0 0  1 0  28 0 
1N2B  APC  0 0  7 8  13 9 
1EYE  PMM  0  0 0  0 0  1 
2C27  MA8  0 0  4 0  19 0 
1N8W  COA  0  27 0  28 0  30 
Total  20 27  78 43  190 83 
Table 5: SMILES string similarity search of X-ray ligands in sixteen protein-ligand co-crystal X-ray structures against the 
top 500 and the bottom 500 docked ligands using Tanimoto coefficients (TC) of 0.5, 0.6, and 0.7, respectively. 
 
 